Allergy Therapeutics Share Price (AGY)
| Bid price | 7.75 | Open price | 8.13 |
|---|---|---|---|
| Ask price | 8.00 | Prev close | 7.88 |
| High price | 8.23 | Spread | 3.13% |
| Low price | 7.00 | Volume | 607,000 |
Register now for FREE live Allergy Therapeutics share prices, Allergy Therapeutics stock quotes, charts, trades and FREE Allergy Therapeutics company fundamentals, market news and much much more. Why not upgrade to a premium service and get Allergy Therapeutics Level 2 Data, indepth research tools and investor commentary for Allergy Therapeutics (AGY) and other London Stock Exchange equities.
Allergy Therapeutics Share Price Chart
Register now for FREE Allergy Therapeutics share price charts
Allergy Therapeutics Share Price Information
| Name | Allergy Therapeutics | Epic | AGY |
|---|---|---|---|
| Activites | Develops, manufactures, markets and sells a range of pharmaceutical vaccine products designed for the immunological treatment | Reuters | AGY.L |
| ISIN | GB00B02LCQ05 | Google Finance | LON:AGY |
| Share Price (p) | 7.88 | Prev. Share Price (p) | 7.88 |
|---|---|---|---|
| Shares in Issue (m) | 407 | Market Cap (£m) | 33 |
| PE Ratio (x) | -16.28 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -0.90 | PEG |
Register now for FREE Allergy Therapeutics company fundamentals
Allergy Therapeutics Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 30/03/2011 | BUY | Peter Jensen | CH | 100,000 |
| 29/03/2011 | BUY | Virinder Nohria | RES | 50,000 |
| 29/03/2011 | BUY | Ignace Goethals | CH | 115,197 |
| 24/03/2010 | EXR | Ian Postlethwaite | FD | 1,000,000 |
| 24/03/2010 | SEXR | Ian Postlethwaite | FD | 507,000 |
Allergy Therapeutics Company News
Drug recall will impact on Allergy Therapeutics
Allergy Therapeutics, the fully integrated specialty pharmaceutical company, has been notified by Lincoln Medical, the producer of Anapen® (adrenaline for injection), that they are undertaking a voluntary drug recall for all unexpired units of Anapen® in the UK, as a precautionary measure....
Voluntary recall of Anapen by Lincoln Medical
/* */ RNS Number : 9322D Allergy Therapeutics PLC 23 May 2012 23 May 2012 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Company") Notification of voluntary product recall of Anapen ®...
Holding(s) in Company
/* */ RNS Number : 6125D Allergy Therapeutics PLC 17 May 2012 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting...
More Allergy Therapeutics Company News >>
Register now for FREE Allergy Therapeutics company news
Allergy Therapeutics Share Price Discussions
Allergy Therapeutics (AGY)
Good results. An over-looked stock although it was flagged up by Shares magazine a couple of months ago. Revenues up and trials proceeding this year means there should be plenty of newsflow. http://www.uk-wire.com/cgi-bin/articles/200503080700074388J.html Very difficult to buy any size...
Register now for FREE Allergy Therapeutics share price discussions